Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benjamin Roeben

Showing results (11-20 of 41) with videos related to

Pageof 5
Sort By:
Frontiers in Aging Neuroscience|October 30, 2024
Machine learning-based personalized composite score dissects risk and protective factors for cognitive and motor function in older participantsAnn-Kathrin Schalkamp, Stefanie Lerche, Isabel Wurster, et al.
NPJ Parkinson'S Disease|April 22, 2024
Longitudinal cognitive decline characterizes the profile of non-PD-manifest GBA1 mutation carriersBenjamin Roeben, Inga Liepelt-Scarfone, Stefanie Lerche, et al.
NPJ Parkinson'S Disease|March 11, 2023
Inflammatory CSF profiles and longitudinal development of cognitive decline in sporadic and GBA-associated PDStefanie Lerche, Milan Zimmermann, Benjamin Roeben, et al.
Journal of Neuropsychology|October 16, 2018
Assessment of cognitive-driven activity of daily living impairment in non-demented Parkinson's patientsSara Becker, Alena Bäumer, Walter Maetzler, et al.
European Journal of Neurology|November 1, 2021
Effects of exergaming on hippocampal volume and brain-derived neurotrophic factor levels in Parkinson's diseaseEva Schaeffer, Benjamin Roeben, Oliver Granert, et al.
Parkinsonism & Related Disorders|June 13, 2026
Impact of genetic variants in the longevity gene PPARGC1A and cerebrospinal fluid PPARγ levels on clinical trajectories in Parkinson's disease: Potential biomarkers for neurodegeneration and ageingMadeleine Fandrich, Claudia Schulte, Meike Jakobi, et al.
NPJ Parkinson'S Disease|December 1, 2025
Quantification of cerebrospinal fluid α-synuclein seeds by endpoint dilution seed amplification assay in Parkinson's diseaseKathrin Brockmann, Alice Ticca, Stefanie Lerche, et al.
Neurology|November 21, 2020
Association of Hippocampal Subfields, CSF Biomarkers, and Cognition in Patients With Parkinson Disease Without DementiaSara Becker, Oliver Granert, Maarten Timmers, et al.
Neurobiology of Aging|July 27, 2018
Deterioration of executive dysfunction in elderly with REM sleep behavior disorder (RBD)Stefanie Lerche, Gerrit Machetanz, Benjamin Roeben, et al.
Frontiers in Neurology|March 14, 2022
CSF and Serum Levels of Inflammatory Markers in PD: Sparse Correlation, Sex Differences and Association With Neurodegenerative BiomarkersStefanie Lerche, Milan Zimmermann, Isabel Wurster, et al.
Pageof 5

Showing results (11-20 of 41) with videos related to

Sort By:
Pageof 5
Frontiers in Aging Neuroscience|October 30, 2024
Machine learning-based personalized composite score dissects risk and protective factors for cognitive and motor function in older participantsAnn-Kathrin Schalkamp, Stefanie Lerche, Isabel Wurster, et al.
NPJ Parkinson'S Disease|April 22, 2024
Longitudinal cognitive decline characterizes the profile of non-PD-manifest GBA1 mutation carriersBenjamin Roeben, Inga Liepelt-Scarfone, Stefanie Lerche, et al.
NPJ Parkinson'S Disease|March 11, 2023
Inflammatory CSF profiles and longitudinal development of cognitive decline in sporadic and GBA-associated PDStefanie Lerche, Milan Zimmermann, Benjamin Roeben, et al.
Journal of Neuropsychology|October 16, 2018
Assessment of cognitive-driven activity of daily living impairment in non-demented Parkinson's patientsSara Becker, Alena Bäumer, Walter Maetzler, et al.
European Journal of Neurology|November 1, 2021
Effects of exergaming on hippocampal volume and brain-derived neurotrophic factor levels in Parkinson's diseaseEva Schaeffer, Benjamin Roeben, Oliver Granert, et al.
Parkinsonism & Related Disorders|June 13, 2026
Impact of genetic variants in the longevity gene PPARGC1A and cerebrospinal fluid PPARγ levels on clinical trajectories in Parkinson's disease: Potential biomarkers for neurodegeneration and ageingMadeleine Fandrich, Claudia Schulte, Meike Jakobi, et al.
NPJ Parkinson'S Disease|December 1, 2025
Quantification of cerebrospinal fluid α-synuclein seeds by endpoint dilution seed amplification assay in Parkinson's diseaseKathrin Brockmann, Alice Ticca, Stefanie Lerche, et al.
Neurology|November 21, 2020
Association of Hippocampal Subfields, CSF Biomarkers, and Cognition in Patients With Parkinson Disease Without DementiaSara Becker, Oliver Granert, Maarten Timmers, et al.
Neurobiology of Aging|July 27, 2018
Deterioration of executive dysfunction in elderly with REM sleep behavior disorder (RBD)Stefanie Lerche, Gerrit Machetanz, Benjamin Roeben, et al.
Frontiers in Neurology|March 14, 2022
CSF and Serum Levels of Inflammatory Markers in PD: Sparse Correlation, Sex Differences and Association With Neurodegenerative BiomarkersStefanie Lerche, Milan Zimmermann, Isabel Wurster, et al.
Pageof 5